BruDashUS

PGNY

Progyny, Inc. $25.23 +1.53% 2026-10-02 종가 기준
차트 불러오는 중…

핵심 지표

yfinance 기준
시가총액1935817088
PER (실적/예상)27.4 / 10.9
PBR4.27
EPS$0.92
배당수익률-
베타0.99
공매도 잔고6.7% 유통주 대비 · 커버 4.6일
52주 고 / 저$28.75 / $16.10
수익률 1주/1달/3달/1년 -0.8 · -3.3 · +49.0 · +6.1
섹터 / 산업Healthcare · Healthcare Plans

분기 실적

매출·순이익 · yfinance
26년 06월 분기 매출 $0.35B · 순익 $0.03B (8.0%) · EPS 0.34
26년 03월 분기 매출 $0.33B · 순익 $0.02B (7.4%) · EPS 0.29
25년 12월 분기 매출 $0.32B · 순익 $0.01B (3.9%) · EPS 0.14
25년 09월 분기 매출 $0.31B · 순익 $0.01B (4.4%) · EPS 0.15
25년 06월 분기 매출 $0.33B · 순익 $0.02B (5.1%) · EPS 0.19

사업 개요

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

관련 뉴스

다중 소스 · 일부 한글 번역
관련 뉴스가 아직 없어요.

애널리스트 컨센서스

Finnhub · 2026-09
강력매수
매수 15 보유 3 매도 0 총 18명

기술 신호

이동평균·RSI · 전일 종가 기준
추세정배열 (상승추세)
20일선 대비-3.7% ($26.20)
50일선 대비+3.1% ($24.48)
200일선 대비+12.9% ($22.34)
RSI(14)23.0 · 과매도

최근 공시

SEC EDGAR

거래

거래량939,641
거래소NMS
외부 링크 Yahoo · TradingView